Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine

Drug and Alcohol Dependence

Volumn 84, Issue 3, 2006, Pages 211-222

  Cunningham, Colin S ^a   Polston, James E ^a   Jany, John R ^a   Segert, Ines L ^a   Miller, Dennis K ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Amphetamine; Cocaine; Lobeline; Nicotine; Nicotinic receptor

Indexed keywords

COCAINE; DEXAMPHETAMINE; HEXAMETHONIUM; LIGAND; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PROCAINE;

ANIMAL EXPERIMENT; ARTICLE; BLOCKING FACTOR; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ABUSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; DRUG SELECTIVITY; DRUG SUBSTITUTION; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

AMPHETAMINE; ANIMALS; COCAINE; DISCRIMINATION (PSYCHOLOGY); HEXAMETHONIUM; LIGANDS; LOBELINE; MALE; MECAMYLAMINE; NARCOTICS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; REINFORCEMENT (PSYCHOLOGY);

EID: 33747855239     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.01.012     Document Type: Article

References (47)

1. Appel J.B., White F.J., and Holohean A.M. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures. Neurosci. Biobehav. Rev. 6 (1982) 529-536
2. Baker L.E., Riddle E.E., Saunders R.B., and Appel J.B. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav. Pharmacol. 4 (1993) 69-79
3. Brioni J.D., O'Neill A.B., Kim D.J., and Decker M.W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238 (1993) 1-8
4. Brown J.M., Hanson G.R., and Fleckenstein A.E. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors. J. Pharmacol. Exp. Ther. 298 (2001) 1150-1153
5. Callahan P.M., Appel J.B., and Cunningham K.A. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103 (1991) 50-55
6. Callahan P.M., de la G.R., and Cunningham K.A. Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol. Biochem. Behav. 57 (1997) 601-607
7. Chance W.T., Murfin D., Krynock G.M., and Rosecrans J.A. A description of the nicotine stimulus and tests of its generalization to amphetamine. Psychopharmacology 55 (1977) 19-26
8. Conover W.J. Practical Nonparametric Statistics (1980), John Wiley & Sons, New York
9. Corrigall W.A., and Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99 (1989) 473-478
10. Court J.A., Perry E.K., Spurden D., Lloyd S., Gillespie J.I., Whiting P., and Barlow R. Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (α4β2) transfected into mouse fibroblasts with ion channel activity. Brain. Res. 667 (1994) 118-122
11. Cunningham K.A., and Callahan P.M. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104 (1991) 177-180
12. Damaj M.I., Slemmer J.E., Carroll F.I., and Martin B.R. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs. J. Pharmacol. Exp. Ther. 289 (1999) 1229-1236
13. Davison G.C., and Rosen R.C. Lobeline and reduction of cigarette smoking. Psychol. Rep. 31 (1972) 443-456
14. Decker M.W., Majchrzak M.J., and Arneric S.P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45 (1993) 571-576
15. Desai R.I., Barber D.J., and Terry P. Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology 167 (2003) 335-343
16. Dwoskin L.P., and Crooks P.A. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem. Pharmacol. 63 (2002) 89-98
17. Eyerman D.J., and Yamamoto B.K. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. J. Pharmacol. Exp. Ther. 312 (2005) 160-169
18. Fudala P.J., and Iwamoto E.T. Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav. 25 (1986) 1041-1049
19. Goudie A., and Reid D. Qualitative discrimination between cocaine and amphetamine in rats. Eur. J. Pharmacol. 151 (1988) 471-474
20. Graham J.H., and Balster R.L. Cocaine-like discriminative stimulus effects of procaine, dimethocaine and lidocaine in rats. Psychopharmacology 110 (1993) 287-294
21. Harrod S.B., Dwoskin L.P., and Bardo M.T. Lobeline produces conditioned taste avoidance in rats. Pharmacol. Biochem. Behav. 78 (2004) 1-5
22. Harrod S.B., Dwoskin L.P., Crooks P.A., Klebaur J.E., and Bardo M.T. Lobeline attenuates d-methamphetamine self-administration in rats. J. Pharmacol. Exp. Ther. 298 (2001) 172-179
23. Harrod S.B., Dwoskin L.P., Green T.A., Gehrke B.J., and Bardo M.T. Lobeline does not serve as a reinforcer in rats. Psychopharmacology 165 (2003) 397-404
24. Hennings E.C., Kiss J.P., De Oliveira K., Toth P.T., and Vizi E.S. Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J. Neurochem. 73 (1999) 1043-1050
25. Kenakin T. Pharmacologic Analysis of Drug-Receptor Interaction (1997), Lippincott-Raven, Philadelphia
26. Kiess H.O. Statistical Concepts for the Behavioral Sciences (1989), Allyn and Bacon, Needham Heights, MA
27. Le Foll B., and Goldberg S.R. Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178 (2005) 481-492
28. Mansbach R.S., Rovetti C.C., and Freedland C.S. The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus. Drug Alcohol. Depend. 52 (1998) 125-134
29. + efflux from thalamic synaptosomes. Neuropharmacology 39 (2000) 2654-2662
30. Miller D.K., Crooks P.A., Teng L., Witkin J.M., Munzar P., Goldberg S.R., Acri J.B., and Dwoskin L.P. Lobeline inhibits the neurochemical and behavioral effects of amphetamine. J. Pharmacol. Exp. Ther. 296 (2001) 1023-1034
31. Miller D.K., Harrod S.B., Green T.A., Wong M.Y., Bardo M.T., and Dwoskin L.P. Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats. Pharmacol. Biochem. Behav. 74 (2003) 279-286
32. Pifl C., Sitte H.H., Reither H., and Singer E.A. The mechanism of the releasing action of amphetamine. Uptake, superfusion, and electrophysiological studies on transporter-transfected cells. Pure. Appl. Chem. 72 (2000) 1045-1050
33. Rasmussen T., and Swedberg M.D. Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 60 (1998) 567-573
34. Reavill C., Walther B., Stolerman I.P., and Testa B. Behavioral and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 29 (1990) 619-624
35. Rose J.E., Sampson A., Levin E.D., and Henningfield J.E. Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol. Biochem. Behav. 32 (1989) 933-938
36. 3H]metabolites in rat striatum by nicotinic drugs. Brain. Res. 242 (1982) 99-106
37. Schechter M.D. Discriminative characteristics of high and low cocaine administration: effect of other psychostimulants. Pharmacol. Biochem. Behav. 56 (1997) 457-463
38. Schechter M.D., and Rosecrans J.A. Nicotine as a discriminative cue in rats: inability of related drugs to produce a nicotine-like cueing effect. Psychopharmacologia 27 (1972) 379-387
39. Shoblock, J.R., Maisonneuve, I.M., Glick, S.D. 2003a. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology (Berl.) 170, 150-156.
40. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., and Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 165 (2003) 359-369
41. Stolerman I.P. Drug stimulus generalization and Gossop's Web of dependence. Addiction 97 (2002) 152-154
42. Stolerman I.P., Garcha H.S., and Mirza N.R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 117 (1995) 430-437
43. Stolerman I.P., Samele C., Kamien J.B., Mariathasan E.A., and Hague D.S. A bibliography of drug discrimination research, 1992-1994. Behav. Pharmacol. 6 (1995) 643-668
44. 3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine. J. Neurochem. 71 (1998) 258-265
45. Terry Jr. A.V., Williamson R., Gattu M., Beach J.W., McCurdy C.R., Sparks J.A., and Pauly J.R. Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine. Neuropharmacology 37 (1998) 93-102
46. Westerink B.H., and Kikkert R.J. Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain. J. Neurochem. 46 (1986) 1145-1152
47. Wilhelm C.J., Johnson R.A., Lysko P.G., Eshleman A.J., and Janowsky A. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. J. Pharmacol. Exp. Ther. 310 (2004) 1142-1151